Insights from the ISPOR Panel on the European Health Data Space

By João L. Carapinha

November 13, 2023

The European Health Data Space (EHDS) represents a groundbreaking initiative by the European Commission, poised to advance healthcare data management across the EU. As discussed in the recent ISPOR Europe conference panel, the EHDS is much more than a tool for pharmacovigilance and retrospective cohort studies.

It’s a comprehensive framework designed to empower EU citizens with equitable access to healthcare data while ensuring data privacy and fostering participation in intellectual property creation.

The EHDS is set to enhance the digitalization of health records and propel research. It supports the efficient utilization of electronic healthcare records and deployment of artificial intelligence for data analysis.

This advancement is not only expected to deepen research capabilities but also to spur innovation and improve policy-making at all societal levels.

Key opportunities presented by the EHDS include increased access to data and the attractiveness of Europe as a hub for clinical research, ultimately translating into improved patient outcomes. However, the implementation of the EHDS is not without challenges. These include ensuring transparency and trust in data sharing, addressing patient willingness to opt into data sharing, and navigating data protection and privacy concerns.

A significant challenge lies in extending the scope of EHDS beyond existing laws and regulations, aiming to build a stronger health data network backed by EU member states’ support.

Furthermore, panelists highlighted the importance of evaluating the readiness of EU member states to participate in the EHDS. Cultural barriers were identified as a critical hurdle, as the EHDS requires substantial organizational changes to facilitate the sharing, storage, and availability of data to various users and the research community.

As the EHDS progresses, it will undergo continuous improvement, driven by feedback from users and researchers accessing the data. This initiative is not just a standalone project but an integral component of the broader European Union. It aligns with the European strategy for data, indicating a holistic approach to data management and utilization across various sectors in the EU, with health data being a priority area.

In summary, the European Health Data Space is an ambitious and transformative project. It holds the promise of reshaping the landscape of healthcare research, policy-making, and industry practices within the EU, setting a precedent for the rest of the world in healthcare data management and utilization.

Reference url

Recent Posts

Fabhalta Kidney Treatment Shows Promise in Slowing Disease Progression for IgA Nephropathy

By João L. Carapinha

October 21, 2025

Novartis has announced positive final results from the Phase III APPLAUSE-IgAN trial, which demonstrated that Fabhalta kidney treatment (iptacopan) achieved a statistically significant and clinically meaningful slowing of kidney function decline in patients with IgA nephropathy compared to placeb...
Keytruda Lung Cancer Treatment: Long-Term Survival Gains in NSCLC

By João L. Carapinha

October 20, 2025

If you're searching for effective options in Keytruda lung cancer treatment, recent data shows pembrolizumab (Keytruda) significantly boosts survival rates in non-small cell lung cancer (NSCLC). In the KEYNOTE-671 trial, this immunotherapy combined with chemotherapy raised five-year overall survi...
Promising PSMA-Targeted Therapy Delays Prostate Cancer Progression
Novartis recently announced pivotal data from the Phase III PSMAddition trial. It demonstrates that PSMA-targeted therapy with Pluvicto™ (lutetium-177 vipivotide tetraxetan) combined with standard of care (androgen receptor pathway inhibitor plus androgen deprivation therapy) significantly reduce...